Results 221 to 230 of about 1,501,016 (387)

Subjective ratings of sleep quality and anxiety after placebo, drug and a food drink [PDF]

, 1976
Kirstine Adam, Liisi Adamson, Ian Oswald
openalex   +1 more source

Cancer and Placebos [PDF]

CA: A Cancer Journal for Clinicians, 1981
openaire   +2 more sources

Effects of 17β-estradiol and equilin on atherosclerosis development in female Apoe^shl mice. [PDF]

Sci Rep
Kakibuchi A, Ito F, Takaoka O, Tahara N, Kawamata M, Yabumoto K, Katayama A, Izumi Y, Maeda E, Mori T.   +9 more
europepmc   +1 more source

SHORT-TERM CLINICAL TRIAL of PROPRANOLOL IN RACEMIC FORM (INDERAL), D-PROPRANOLOL and PLACEBO IN MIGRAINE

, 1976
Per Stensrud, Ottar Sjaastad
openalex   +1 more source

Placebo and placebo effects in medicine [PDF]

Journal of the Royal Society of Medicine, 2000
Michael Emmans Dean, Joseph S Conway
openaire   +2 more sources

First‐in‐human safety, tolerability, pharmacokinetics and pilot food‐effect study of the candidate antimalarial compound MMV367

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aim To evaluate the safety, tolerability and pharmacokinetics in healthy participants of orally administered MMV367 (GSK3772701), a novel antimalarial interfering with Plasmodium falciparum acyl coenzyme A synthetase 10/11 function. Methods This first‐in‐human study enrolled 47 healthy male and female participants.
Andrea Kuemmerle, Nand Singh, Denis Gossen, Annick Janin, Raman Sharma, Anthony Cahn, Rachel A. Gibson, Somasekhara R. Menakuru, Erin Lambourne, Tom Dove, Francisco‐Javier Gamo, Laura Sanz, Benoit Bestgen, Stephan Chalon   +13 more
wiley   +1 more source

Belimumab efficacy in mucocutaneous manifestations of systemic lupus erythematosus: a large post hoc analysis of five phase III clinical trials. [PDF]

Rheumatology (Oxford)
Grosso G, Giannopoulou N, Tsoi A, Cetrez N, Nikolopoulos D, Lindblom J, Parodis I.   +6 more
europepmc   +1 more source

Placebo – Nocebo [PDF]

Kompass Onkologie, 2020
openaire   +5 more sources

Sobre placebo e efeito placebo [PDF]

Revista Latinoamericana de Psicopatologia Fundamental, 2002
Mônica Teixeira, Erney Plessmann de Camargo   +1 more
openaire   +2 more sources

Safety, tolerability, pharmacokinetics and pharmacodynamics of HSK31858, a novel oral dipeptidyl peptidase‐1 inhibitor, in healthy volunteers: An integrated phase 1, randomized, double‐blind, placebo‐controlled, single‐ and multiple‐ascending dose study

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aim Dipeptidyl peptidase‐1 (DPP‐1) inhibitors have been studied for the treatment of neutrophil‐mediated inflammatory diseases including bronchiectasis, bronchial asthma and cystic fibrosis. This study evaluated the pharmacokinetics, pharmacodynamics, safety and tolerability of DPP‐1 inhibitor HSK31858 in healthy Chinese volunteers.
Yuhao Wang, Chao Yu, Mengyue Hu, Lu Wang, Meixia Chen, Hanmo Liu, Nan Wu, Jie Hou   +7 more
wiley   +1 more source